DeepScan Logo
HomeAbout
Clinic FinderContact
Clinic Dashboard
HomeBlogSepsis vs. SIRS: Can DNA Tell the Difference?

Sepsis vs. SIRS: Can DNA Tell the Difference?

DeepScan Marketing
11/10/2025
2 min read
Sepsis vs. SIRS: Can DNA Tell the Difference?

Inflammation looks a lot like infection on a blood panel. We explore why cfDNA rises in both, and how it helps quantify the 'cytokine storm'.

Sepsis vs. SIRS: Can DNA Tell the Difference?

One of the hardest challenges in the ICU is distinguishing Sepsis (infection) from SIRS (Systemic Inflammatory Response Syndrome, e.g., severe pancreatitis or heatstroke). Both present with fever, tachycardia, and high white counts.

Can cfDNA distinguish them?

The Short Answer: No.

Studies in both human and veterinary medicine show that cfDNA is a marker of inflammation-induced cell damage, regardless of the trigger.

* Sepsis: Bacterial toxins kill cells -> DNA release.
* Sterile SIRS: Pancreatic enzymes or heat damage kill cells -> DNA release.

In canine studies, cfDNA levels overlap significantly between septic and non-septic SIRS patients. You cannot use cfDNA to decide whether to start antibiotics.

The Long Answer: It's About Severity.

While it doesn't tell you the cause, it tells you the magnitude.

CRP (C-Reactive Protein) tells you the immune system is angry. cfDNA tells you that cells are actually dying.

The "Discordant" Patient:
Imagine a dog with Pancreatitis.
* Scenario A: High CRP, Normal cfDNA.
Interpretation:* Significant inflammation, but the pancreas is intact. Good prognosis.
* Scenario B: High CRP, Massive cfDNA.
Interpretation:* Necrotizing pancreatitis. Cells are liquefying. High risk of DIC and organ failure.

Future Tech: Metagenomics

There is an emerging application called "Metagenomic Sequencing." Instead of sequencing the dog's DNA, the lab sequences all the DNA in the blood to find non-canine DNA (bacteria).

Future Workflow: Sample drawn. Lab subtracts the dog DNA. Lab identifies E. coli* DNA remaining.

This technology is currently expensive and research-focused, but it represents the future of sepsis diagnosis.

Share this article

Related Articles

cfDNA 101: The Biology of the 'Liquid Biopsy' in Veterinary Medicine

cfDNA 101: The Biology of the 'Liquid Biopsy' in Veterinary Medicine

A deep dive into the origins of cell-free DNA—apoptosis, necrosis, and NETosis—and why this 'real-time' biomarker is revolutionizing veterinary diagnostics.

The Golden Rules: A Clinic SOP for Preanalytical cfDNA Handling

The Golden Rules: A Clinic SOP for Preanalytical cfDNA Handling

A missed 10-minute window or a single freeze-thaw cycle can ruin a liquid biopsy. Here is the strict Standard Operating Procedure (SOP) every clinic needs.

Defining 'Normal': Reference Intervals and Biological Variation in Dogs

Defining 'Normal': Reference Intervals and Biological Variation in Dogs

How much cfDNA is too much? We review the data on healthy baselines, the impact of age and breed, and why '0.0' is not the goal.

View all articles
DeepScan Logo

We provide innovative diagnostic solutions for veterinarians, enabling early detection of canine cancer through advanced CFD biomarker testing.

Contact Information

  • Elimäenkatu 17-19

    00510 Helsinki, Finland

  • contact@deepscandx.com
  • +358 50 5282125

Navigation

  • Home
  • About Us
  • Find Clinics
  • For Veterinarians
  • FAQ
  • Contact

Resources

  • Blog
  • News
  • Webinars
  • Research
  • CFD Test Info
  • Privacy Policy
  • Cookie Policy

© 2025 DeepScan Diagnostics. All rights reserved.